Key result
nNOS inhibition shortens human atrial action potential duration and doubles murine AF inducibility.
Why the study?
Neuronal nitric oxide synthase (nNOS) activity is dramatically reduced in atrial myocytes from patients with AF, and whether this loss contributes to AF-induced atrial electrical remodelling remained to be established.
Does loss or inhibition of myocardial nNOS activity shorten action potential duration by increasing Ito and promote AF-induced electrical remodelling in human and murine atrial myocytes?
Does loss or inhibition of myocardial nNOS activity shorten action potential duration by increasing Ito and promote AF-induced electrical remodelling in human and murine atrial myocytes?
Loss of myocardial nNOS-derived nitric oxide shortens atrial action potential duration and impairs rate-dependent adaptation via increased Ito current, directly contributing to atrial fibrillation electrical remodelling and inducibility.
Answers are grounded in this paper and cite their sources.
Reduced nNOS in AF atria may promote electrical remodeling; leaves open whether restoring nNOS prevents AF progression.
Purpose: Understanding the mechanism underlying atrial electrical remodelling in AF is of fundamental importance for the prevention and treatment of AF. We have recently found that neuronal nitric oxide synthase (nNOS) activity is dramatically reduced in atrial myocytes from patients with AF. Whether loss of nNOS activity contributes to AF-induced atrial electrical remodelling remains to be established. Methods: Whole-cell patch clamp was used to record action potentials (APs) and ion currents in human and murine right atrial myocytes. AF was induced in isoflurane anaesthetised mice by using trans-oesophageal electrical stimulation. N=number of patients or mice, n= number of myocytes. Results: Inhibition of nNOS by S-methylthiocitrulline (SMTC, 100 nM), induced a significant reduction in APD at 20 (38%), 50 (39%) and 90 (30%) percent of repolarization in atrial myocytes from patients in sinus rhythm (SR, N=8, n=38 control vs. N=8, n=31 in the presence SMTC, p<0.001) and suppressed APD rate-dependent adaptation (from 0.5 to 3 Hertz, N=6, n=24 control vs. N=6, n=17 cells with SMTC, p<0.05). In mice, nNOS inhibition or gene deletion reduced APD50 by 46% and 29%, respectively. (N=9, n=35 from nNOS-/- & N=6, n=11 WT plus SMTC vs. N=10, n=28 WT control, p<0.001 for the effect of nNOS dysruption). By contrast, SMTC had no effect on APD in atrial myocytes from patients with AF or nNOS-/- mice. In agreement with these findings, nNOS-/- mice displayed a 2-fold increase in AF inducibility in response to burst stimulation (p<0.05 vs. WT littermates, N=18 per genotype). Investigations of the ionic changes underlying the effect of nNOS dysruption on APD in RA myocytes from patients in SR (N=7, n=31 control vs. N=7, n=35 in SMTC) or WT mice with SMTC (N=9, n=19 control via N=6, n=9 in SMTC) showed an increase in Ito with SMTC in both species with no change in IK1 or IKr. Ito blockade with 4-AP (0.5 mM) significantly prolonged APD20 (by 19% in SR and by 153% in SMTC), APD50 (by 19% in SR and by 55% in SMTC) and, to a lesser extent, APD90 (by 7% in SR and by 13% in SMTC) in atrial myocytes from patients in SR. 4-AP also recovered the APD rate dependent adaptation that was suppressed by SMTC, confirming a role of Ito in the nNOS regulation of APD in human atrial myocytes. Conclusions: In mammalian atrial myocytes, nNOS-derived NO plays an important role in the regulation of APD and its rate-dependent adaptation by modulating Ito. These findings suggest that the marked loss of nNOS protein and activity in the fibrillating atrial myocardium has potentially important implication for AF-induced electrical remodelling.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2014) studied Atrial fibrillation (AF) and sinus rhythm (SR) in human right atrial myocytes and murine models. nNOS inhibition (S-methylthiocitrulline [SMTC]) or nNOS gene deletion (nNOS-/-) vs. Control myocytes without SMTC and wild-type (WT) littermate mice was evaluated on Action potential duration (APD20, APD50, APD90) and AF inducibility (p=<0.001). nNOS inhibition with SMTC reduced APD20 by 38%, APD50 by 39%, and APD90 by 30% in human sinus rhythm atrial myocytes (p<0.001), while nNOS-/- mice had a 2-fold increase in AF inducibility (p<0.05).
Synapse has enriched 10 related papers. Consider them for comparative context: